Progression models for repeated measures: estimating novel treatment effects in progressive diseases
From MaRDI portal
Publication:6629393
Cites work
Cited in
(4)- Testing disease progression under the proportional reduction in decline in Alzheimer's disease studies
- Comments on: ``Novel non-linear models for clinical trial analysis with longitudinal data: a tutorial using SAS for both frequentist and Bayesian methods
- Confidence intervals for saved time to interpret treatment effects in Alzheimer's disease studies
- Time-scale target parameters and two-step estimation in longitudinal trials for progressive diseases
This page was built for publication: Progression models for repeated measures: estimating novel treatment effects in progressive diseases
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629393)